zepp health - ZEPP

ZEPP

Close Chg Chg %
27.40 -0.43 -1.55%

Closed Market

26.97

-0.43 (1.55%)

Volume: 77.54K

Last Updated:

Dec 31, 2025, 3:59 PM EDT

Company Overview: zepp health - ZEPP

ZEPP Key Data

Open

$26.85

Day Range

26.43 - 27.40

52 Week Range

2.13 - 61.84

Market Cap

$189.73M

Shares Outstanding

7.04M

Public Float

7.04M

Beta

1.47

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$4.11

Yield

0.00%

Dividend

$0.08

EX-DIVIDEND DATE

Mar 25, 2022

SHORT INTEREST

N/A

AVERAGE VOLUME

169.06K

 

ZEPP Performance

1 Week
 
-4.70%
 
1 Month
 
-5.74%
 
3 Months
 
-45.79%
 
1 Year
 
936.15%
 
5 Years
 
-43.16%
 

ZEPP Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About zepp health - ZEPP

Zepp Health Corp. engages in the development of smart wearable health and consumer fitness devices. It empowers users to achieve their well-being goals by optimizing their health, fitness, and wellness journeys. Its brands include Amazfit, Zepp Clarity, and Zepp Aura. The company was founded by Huang Wang in 2013 and is headquartered in Gorinchem, Netherlands.

ZEPP At a Glance

Zepp Health Corp.
Edisonweg 44–B08
Gorinchem, Groningen 4207 HG
Phone 31-616-086-658 Revenue 182.69M
Industry Other Consumer Specialties Net Income -75,921,061.26
Sector Consumer Durables Employees 765
Fiscal Year-end 12 / 2025
View SEC Filings

ZEPP Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.23
Price to Book Ratio 0.15
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -2.689
Enterprise Value to Sales 0.622
Total Debt to Enterprise Value 1.603

ZEPP Efficiency

Revenue/Employee 238,816.457
Income Per Employee -99,243.217
Receivables Turnover 2.308
Total Asset Turnover 0.314

ZEPP Liquidity

Current Ratio 1.288
Quick Ratio 0.997
Cash Ratio 0.572

ZEPP Profitability

Gross Margin 38.463
Operating Margin -25.876
Pretax Margin -31.71
Net Margin -41.556
Return on Assets -13.036
Return on Equity -25.179
Return on Total Capital -17.504
Return on Invested Capital -18.894

ZEPP Capital Structure

Total Debt to Total Equity 72.395
Total Debt to Total Capital 41.994
Total Debt to Total Assets 34.457
Long-Term Debt to Equity 30.704
Long-Term Debt to Total Capital 17.81
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Zepp Health - ZEPP

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
969.11M 615.24M 352.20M 182.69M
Sales Growth
+3.97% -36.51% -42.75% -48.13%
Cost of Goods Sold (COGS) incl D&A
766.66M 495.97M 259.36M 112.43M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
8.04M 8.71M 7.69M 5.02M
Depreciation
5.44M 6.15M 5.19M 2.57M
Amortization of Intangibles
2.60M 2.56M 2.49M 2.45M
COGS Growth
+3.74% -35.31% -47.71% -56.65%
Gross Income
202.45M 119.27M 92.84M 70.27M
Gross Income Growth
+4.85% -41.09% -22.16% -24.31%
Gross Profit Margin
+20.89% +19.39% +26.36% +38.46%
2021 2022 2023 2024 5-year trend
SG&A Expense
187.88M 180.19M 122.07M 117.54M
Research & Development
79.87M 76.80M 51.07M 46.18M
Other SG&A
108.01M 103.40M 71.00M 71.36M
SGA Growth
+11.94% -4.09% -32.25% -3.71%
Other Operating Expense
- - - -
-
Unusual Expense
- (5.64M) 143.12K 8.12M
EBIT after Unusual Expense
14.57M (55.29M) (29.37M) (55.40M)
Non Operating Income/Expense
8.93M 8.43M 2.69M 3.02M
Non-Operating Interest Income
2.59M 1.83M 3.20M 3.67M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
6.96M 8.47M 6.73M 5.55M
Interest Expense Growth
- +21.63% -20.46% -17.50%
Gross Interest Expense
6.96M 8.47M 6.73M 5.55M
Interest Capitalized
- - - -
-
Pretax Income
16.54M (55.32M) (33.42M) (57.93M)
Pretax Income Growth
-57.02% -434.49% +39.59% -73.35%
Pretax Margin
+1.71% -8.99% -9.49% -31.71%
Income Tax
1.67M (9.78M) (2.23M) 13.70M
Income Tax - Current - Domestic
4.89M 56.28K 409.74K 248.12K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(3.22M) (9.84M) (2.64M) 13.45M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
21.23M (42.92M) (30.00M) (75.85M)
Minority Interest Expense
(131.95K) (102.91K) (65.63K) 75.04K
Net Income
21.37M (42.82M) (29.94M) (75.92M)
Net Income Growth
-35.53% -300.38% +30.08% -153.59%
Net Margin Growth
+2.20% -6.96% -8.50% -41.56%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
21.37M (42.82M) (29.94M) (75.92M)
Preferred Dividends
- - - -
-
Net Income Available to Common
21.37M (42.82M) (29.94M) (75.77M)
EPS (Basic)
1.3557 -2.7816 -1.9702 -4.6831
EPS (Basic) Growth
-36.47% -305.18% +29.17% -137.70%
Basic Shares Outstanding
15.76M 15.39M 15.20M 16.18M
EPS (Diluted)
1.2932 -2.7816 -1.9702 -4.6831
EPS (Diluted) Growth
-36.51% -315.09% +29.17% -137.70%
Diluted Shares Outstanding
16.52M 15.39M 15.20M 16.18M
EBITDA
22.61M (52.22M) (21.55M) (42.25M)
EBITDA Growth
-22.48% -330.94% +58.74% -96.11%
EBITDA Margin
+2.33% -8.49% -6.12% -23.13%

Snapshot

Average Recommendation BUY Average Target Price 60.23
Number of Ratings 1 Current Quarters Estimate N/A
FY Report Date N/A Current Year's Estimate -0.01
Last Quarter’s Earnings -0.04 Median PE on CY Estimate N/A
Year Ago Earnings -0.11 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates N/A N/A 1 N/A
Mean Estimate N/A N/A -0.01 N/A
High Estimates N/A N/A -0.01 N/A
Low Estimate N/A N/A -0.01 N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 1
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Overweight

Zepp Health in the News